Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Basic characteristics of study subjects

Variable Total
(n = 1,077)
Helicobacter pylori seropositive by GENEDIA®
(n = 651)
H. pylori seronegative by GENEDIA®
(n = 426)
P-value
Sex < 0.001
Male 652 (60.5) 428 (65.7) 224 (52.6)
Female 425 (39.5) 223 (34.3) 202 (47.4)
Age (yr) 58.01 ± 13.25 58.25 ± 12.38 57.68 ± 14.50 0.500
Smoking 0.022
Never 476 (44.6) 267 (41.5) 209 (49.4)
Ex-smoker 221 (20.7) 147 (22.8) 74 (17.5)
Current smoker 370 (34.7) 230 (35.7) 140 (33.1)
Alcohol drinking 0.009
Never 588 (55.2) 336 (52.3) 252 (59.7)
Ex-drinker 316 (29.7) 213 (33.1) 103 (24.4)
Current drinker 161 (15.1) 94 (14.6) 67 (15.9)
Previous H. pylori eradication history 0.106
No 886 (85.2) 550 (86.6) 336 (83.0)
Yes 154 (14.8) 85 (13.4) 69 (17.0)
Endoscopic findings < 0.001
Normal control 327 (30.4) 137 (21.1) 190 (44.6)
Duodenal ulcer 87 (8.1) 64 (9.8) 23 (5.4)
Gastric ulcer 138 (12.8) 92 (14.1) 46 (10.8)
Gastric adenoma 166 (15.4) 119 (18.3) 47 (11.0)
Gastric cancer 359 (33.3) 239 (36.7) 120 (28.2)
H. pylori serology by GastroPanel® < 0.001
Negative 418 (38.8) 67 (10.3) 351 (82.4)
Positive 659 (61.2) 584 (89.7) 75 (17.6)

Values are presented as number (%) or mean ± SD. Values are measured using. GENEDIA® (GENEDIA H. pylori ELISA, Green Cross Co.) and GastroPanel® (GastroPanel ELISA, Biohit Oyj) kits.

J Cancer Prev 2024;29:148~156 https://doi.org/10.15430/JCP.24.024
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd